Cargando…
Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches
Breast cancer (BC) is the leading cause of cancer death in women and the second-most common cancer. An estimated 281 550 new cases of invasive BC will be diagnosed in women in the United States, and about 43 600 will die during 2021. Continual research has shed light on all disease areas, including...
Autores principales: | Schick, Jason, Ritchie, Raquel P, Restini, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100889/ https://www.ncbi.nlm.nih.gov/pubmed/33994789 http://dx.doi.org/10.1177/1178223421995854 |
Ejemplares similares
-
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020) -
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
por: Wintrich, Jan, et al.
Publicado: (2020) -
Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas
por: Ngu, Henry S., et al.
Publicado: (2023) -
Breast microcalcifications: Past, present and future (Review)
por: Logullo, Angela F., et al.
Publicado: (2022) -
Molecular Biomarkers for Celiac Disease: Past, Present and Future
por: Ramírez-Sánchez, Aarón D., et al.
Publicado: (2020)